Skip to main content

Table 2 Cox regression analysis of overall survival in patients with hepatocellular carcinoma

From: MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway

Variables Univariate analysis Multivariate analysis
P value HR 95% CI P value HR 95% CI
MYO18B expression (high/low) 0.002 2.993 1.505–5.952 0.039 2.132 1.038–4.380
Age(<60/≥60) 0.114 0.605 0.324–1.129    
Gender(female/male) 0.324 1.373 0.731–2.576    
Grade(G1 + G2/G3 + G4) 0.463 0.775 0.393–1.530    
Pathologic-Stage (I + II/III + IV) 0.000 3.708 1.790–7.678 0.739 1.421 0.181–11.186
Pathologic-T (T1 + T2/T3 + T4) 0.000 3.783 1.855–7.718 0.461 2.133 0.285–15.989
Pathologic-M (M0/M1) 0.052 3.267 0.991–10.769    
Pathologic-N (N0/N1) 0.080 2.351 0.902–6.130    
  1. HR hazard ratio, CI confidence interval